Searched for: school:LISOM
Factors Associated With Stroke Recurrence After Initial Diagnosis of Cervical Artery Dissection
Mandel, Daniel M; Shu, Liqi; Chang, Christopher; Jack, Naomi; Leon Guerrero, Christopher R; Henninger, Nils; Muppa, Jayachandra; Affan, Muhammad; Ul Haq Lodhi, Omair; Heldner, Mirjam R; Antonenko, Kateryna; Seiffge, David; Arnold, Marcel; Salehi Omran, Setareh; Crandall, Ross; Lester, Evan; Lopez Mena, Diego; Arauz, Antonio; Nehme, Ahmad; Boulanger, Marion; Touze, Emmanuel; Sousa, Joao Andre; Sargento-Freitas, Joao; Barata, Vasco; Castro-Chaves, Paulo; Brito, Maria Teresa; Khan, Muhib; Mallick, Dania; Rothstein, Aaron; Khazaal, Ossama; Kaufman, Josefin E; Engelter, Stefan T; Traenka, Christopher; Aguiar de Sousa, Diana; Soares, Mafalda; Rosa, Sara; Zhou, Lily W; Gandhi, Preet; Field, Thalia S; Mancini, Steven; Metanis, Issa; Leker, Ronen R; Pan, Kelly; Dantu, Vishnu; Baumgartner, Karl; Burton, Tina; von Rennenberg, Regina; Nolte, Christian H; Choi, Richard; MacDonald, Jason; Bavarsad Shahripour, Reza; Guo, Xiaofan; Ghannam, Malik; Almajali, Mohammad; Samaniego, Edgar A; Sanchez, Sebastian; Rioux, Bastien; Zine-Eddine, Faycal; Poppe, Alexandre; Fonseca, Ana Catarina; Fortuna Baptista, Maria; Cruz, Diana; Romoli, Michele; De Marco, Giovanna; Longoni, Marco; Keser, Zafer; Griffin, Kim; Kuohn, Lindsey; Frontera, Jennifer; Amar, Jordan; Giles, James; Zedde, Marialuisa; Pascarella, Rosario; Grisendi, Ilaria; Nzwalo, Hipolito; Liebeskind, David S; Molaie, Amir; Cavalier, Annie; Kam, Wayneho; Mac Grory, Brian; Al Kasab, Sami; Anadani, Mohammad; Kicielinski, Kimberly; Eltatawy, Ali; Chervak, Lina; Chulluncuy Rivas, Roberto; Aziz, Yasmin; Bakradze, Ekaterina; Tran, Thanh Lam; Rodrigo Gisbert, Marc; Requena, Manuel; Saleh Velez, Faddi; Ortiz Gracia, Jorge; Muddasani, Varsha; de Havenon, Adam; Vishnu, Venugopalan Y; Yaddanapudi, Sridhara; Adams, Latasha; Browngoehl, Abigail; Ranasinghe, Tamra; Dunston, Randy; Lynch, Zachary; Penckofer, Mary; Siegler, James E; Mayer, Silvia; Willey, Joshua; Zubair, Adeel; Cheng, Yee Kuang; Sharma, Richa; Marto, João Pedro; Mendes Ferreira, Vítor; Klein, Piers; Nguyen, Thanh N; Asad, Syed Daniyal; Sarwat, Zoha; Balabhadra, Anvesh; Patel, Shivam; Secchi, Thais; Martins, Sheila; Mantovani, Gabriel; Kim, Young Dae; Krishnaiah, Balaji; Elangovan, Cheran; Lingam, Sivani; Quereshi, Abid; Fridman, Sebastian; Alvarado, Alonso; Khasiyev, Farid; Linares, Guillermo; Mannino, Marina; Terruso, Valeria; Vassilopoulou, Sofia; Tentolouris-Piperas, Vasileios; Martinez Marino, Manuel; Carrasco Wall, Victor; Indraswari, Fransisca; El Jamal, Sleiman; Liu, Shilin; Alvi, Muhammad; Ali, Farman; Sarvath, Mohammed; Morsi, Rami Z; Kass-Hout, Tareq; Shi, Feina; Zhang, Jinhua; Sokhi, Dilraj; Said, Jamil; Mongare, Newnex; Simpkins, Alexis; Gomez, Roberto; Sen, Shayak; Ghani, Mohammad; Elnazeir, Marwa; Xiao, Han; Kala, Narendra; Khan, Farhan; Stretz, Christoph; Mohammadzadeh, Nahid; Goldstein, Eric; Furie, Karen; Yaghi, Shadi
BACKGROUND/UNASSIGNED:Patients presenting with cervical artery dissection (CAD) are at risk for subsequent ischemic events. We aimed to identify characteristics that are associated with increased risk of ischemic stroke after initial presentation of CAD and to evaluate the differential impact of anticoagulant versus antiplatelet therapy in these high-risk individuals. METHODS/UNASSIGNED:This was a preplanned secondary analysis of the STOP-CAD study (Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection), a multicenter international retrospective observational study (63 sites from 16 countries in North America, South America, Europe, Asia, and Africa) that included patients with CAD predominantly between January 2015 and June 2022. The primary outcome was subsequent ischemic stroke by day 180 after diagnosis. Clinical and imaging variables were compared between those with versus without subsequent ischemic stroke. Significant factors associated with subsequent stroke risk were identified using stepwise Cox regression. Associations between subsequent ischemic stroke risk and antithrombotic therapy type (anticoagulation versus antiplatelets) among patients with identified risk factors were explored using adjusted Cox regression. RESULTS/UNASSIGNED:=0.01). CONCLUSIONS/UNASSIGNED:In this post hoc analysis of the STOP-CAD study, several factors associated with subsequent ischemic stroke were identified among patients with CAD. Furthermore, we identified a potential benefit of anticoagulation in patients with CAD with occlusive dissection. These findings require validation by meta-analyses of prior studies to formulate optimal treatment strategies for specific high-risk CAD subgroups.
PMID: 40143807
ISSN: 1524-4628
CID: 5816392
Advocacy in Academic Medicine
Casey, Frances; Bingham, Dawn
PMID: 40499073
ISSN: 1931-843x
CID: 5869362
When Accelerated MD Program Is Not the Right Path: The Why and How to Support Accelerated Learners in the Transition to the 4-Year Program
Macerollo, Allison; Santen, Sally A; Brenner, Judith; Cangiarella, Joan; Gonzalez-Flores, Alicia; Jones, Betsy Goebel; Leong, Shou Ling; Roberts, Caroline; Traba, Christin; Vitto, Christina M; Strano-Paul, Lisa
Accelerated 3-year medical school programs (A3YP) allow students to complete medical school in 3 years rather than the traditional 4-year program (4YP). This paper describes the perspective of 14 A3YPs, exploring the rate of and reasons for transition out of an accelerated pathway into a traditional 4YP. As of 2023, 19% of students in A3YP transitioned to 4YP. The authors provide practical recommendations to guide transitions based on pooled experiences and expert consensus from members of the Consortium of Accelerated Medical Pathway Programs (CAMPP). Having clear policies that define academic, clinical, and professional expectations and processes to guide transition is important.
PMCID:12228619
PMID: 40625988
ISSN: 2156-8650
CID: 5890562
A case of renal cell carcinoma with tumor thrombus extension into the right atrium [Case Report]
Whiting, Adrian; Shah, Nairuti; Zucker, Jordan; Gill, Manroop; Sachsenmeier, Eliot; Singh, Paramvir; Ahmed, Kinza; Upadhyay, Rutul; Bender, Michael
INTRODUCTION/UNASSIGNED:Over the last half-century, mortality from renal cell carcinoma (RCC) has seen a dramatic reduction, while 5-year survival rates have reached an all-time high (34% to 75%). CASE PRESENTATION/UNASSIGNED:A 77-year-old female with Stage 4 RCC (cT3c, cN1, cM1) presented with acute onset chest and back pain. Imaging revealed interval enlargement of a left renal mass with propagation of tumor thrombus (TT) throughout the left renal vein, intrahepatic and suprahepatic inferior vena cava (IVC) with extension into the right atrium (RA). The patient successfully underwent a high-risk open left nephrectomy with caval thrombectomy, retroperitoneal lymph node dissection, and atrial thrombectomy. DISCUSSION/UNASSIGNED:Approximately, 1% of RCC cases involve the right atrium, and radical nephrectomy with vena caval thrombectomy remains the most effective treatment for cavoatrial TT, with 5-year survival rates between 30% and 72%. While patients with renal vein involvement have better survival rates than those with IVC involvement, advanced TT cases (Types III and IV) often require extracorporeal circulation. Though the patient understood the prognosis of her RCC, discussing the risks of a complex procedure versus not intervening was challenging. Despite a typical median survival of 12 months for level IV tumor thrombus (TT), she remains stable 28 months post-surgery. CONCLUSION/UNASSIGNED:Although the 5-year survival rate for renal cell carcinoma (RCC) has increased from 34% to 75%, the disease still adversely affects patients' quality of life. A multidisciplinary approach is essential when managing metastatic RCC, particularly involving the heart. Despite the associated risks, surgical intervention is more effective in prolonging life by preventing sudden cardiac death due to embolic events.
PMCID:12140791
PMID: 40486613
ISSN: 2049-0801
CID: 5868932
Occupational and Environmental Cholangiocarcinoma-Related Toxic Exposures
She, Tianyu; Shah, Nairuti; Jacob, Benna; Starkman, Nathan; Lieman, Julie; Kaur, Amandeep; Shah, Neal; Wilkenfeld, Marc
Cholangiocarcinoma (CCA) is a malignancy that originates from the epithelial cells of the biliary system. Despite advancements in medical diagnostic techniques, CCAs remain a challenge to detect due to their silent clinical progression, making it difficult to diagnose these diseases. There are several well-established risk factors for CCA, including biliary tract infection and inflammation. However, there is also growing evidence that community and occupational exposures play a significant role in the development of bile duct cancers. This review examines the geographical distribution of these risk factors and the importance of surveillance in individuals exposed to these toxins who are more prone to developing CCA.
PMCID:12133134
PMID: 40469206
ISSN: 2341-4545
CID: 5862612
5-Year Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients
Hahn, Rebecca T; Ternacle, Julien; Silva, Iria; Giuliani, Carlos; Zanuttini, Antonela; Théron, Alexis; Cristell, Nicole; Bernier, Mathieu; Skaf, Sabah; Beaudoin, Jonathan; Kodali, Susheel K; Russo, Mark; Kapadia, Samir R; Malaisrie, Chris S; Cohen, David J; Leipsic, Jonathon; Blanke, Philipp; Williams, Mathew R; McCabe, James M; Brown, David L; Babaliaros, Vasilis; Goldman, Scott; Szeto, Wilson Y; Généreux, Philippe; Pershad, Ashish; Park, Brandon; Gunnarsson, Marissa; Webb, John G; Smith, Craig R; Makkar, Raj; Thourani, Vinod H; Mack, Michael J; Leon, Martin B; Pibarot, Philippe; ,
BACKGROUND:The PARTNER 3 (Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients with Aortic Stenosis) trial compared SAPIEN 3 transcatheter aortic valve replacement (TAVR) to surgery in low-risk patients with symptomatic, severe aortic stenosis. Echocardiographic outcomes at 5 years are unknown. OBJECTIVES/OBJECTIVE:This study sought to compare 5-year echocardiographic results of TAVR and surgery in the PARTNER 3 trial. METHODS:Echocardiograms for 1,000 randomized patients were obtained at baseline, 30 days, 1 year, and annually through 5 years and were analyzed by a core lab consortium. The composite primary endpoint of death, stroke, or rehospitalization was adjudicated by a clinical events committee. RESULTS:At 5 years, ≥ mild aortic regurgitation was higher following TAVR vs surgery (24.5% vs 6.3%; P < 0.001), with low ≥ moderate aortic regurgitation in both groups. TAVR patients had higher mean transaortic gradient (12.8 ± 6.5 vs 11.7 ± 5.6 mm Hg; P < 0.001), stroke volume index (44.6 ± 9.7 vs 41.1 ± 9.2; P < 0.0001), and aortic valve area (1.87 ± 0.46 vs 1.82 ± 0.46; P = 0.895). Fewer TAVR patients had low-flow stroke volume index (P < 0.001) and left ventricular hemodynamic burden (valvulo-arterial impedance; P < 0.01). Tricuspid annular plane systolic excursion was also higher with TAVR (P < 0.001), as was right ventricular-to-pulmonary artery coupling (P < 0.0001). In the combined cohorts, 30-day moderate to severe prosthesis-patient mismatch, mild to severe aortic regurgitation, or low stroke volume index were not predictive of clinical outcomes; only low right ventricular-to-pulmonary artery coupling and high valvulo-arterial impedance at 30 days were associated with increased risk of the 5-year composite primary endpoint. CONCLUSIONS:In low-risk patients with severe aortic stenosis, TAVR, compared to surgery, was associated with similar, stable valve hemodynamics at 5 years with less frequent low-flow state, lower valvulo-arterial impedance, and better right ventricular function. (PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients with Aortic Stenosis [P3]; NCT02675114).
PMID: 40243974
ISSN: 1876-7591
CID: 5828622
Long-term Effects of Mavacamten on Patients Based on Hypertrophic Cardiomyopathy Pathogenic Genetic Variant Status: Insights from VALOR-HCM Trial
Desai, Milind Y; Owens, Anjali; Saberi, Sara; Wang, Andrew; Wolski, Kathy; Cremer, Paul C; Lakdawala, Neal K; Tower-Rader, Albree; Zenker, Mark; Sherrid, Mark; Geske, Jeffrey B; Fermin, David; Naidu, Srihari S; Lampl, Kathy; Nissen, Steven E
PMID: 40163785
ISSN: 2574-8300
CID: 5818792
Inpatient Child and Adolescent Psychiatry Youth with Autism and/or Intellectual Disabilities: Clinical Characteristics and Considerations
Morris, Arielle M; Lynch, Sean; Kasdin, Rachel G; Hill, Isabela; Shah, Salonee; Shanker, Parul; Becker, Timothy D; Staudenmaier, Paige; Leong, Alicia W; Martin, Dalton; Rice, Timothy
Children and adolescents with autism spectrum disorder and/or an intellectual disability (ASD/ID) are psychiatrically hospitalized at disproportionately higher rates than youth without ASD/ID. Despite this, few studies have compared the clinical courses of youth with and without ASD/ID in inpatient (IP) child and adolescent psychiatry (CAP) settings. This study used a cross-sectional design of all youth (M = 14.0 years, SD = 2.6 years) admitted to an urban IP unit between 2018 and 2021 to examine differences between ASD/ID and non-ASD/ID youth across dimensions of sociodemographic and psychiatric history and clinical course. 1101 Patients were included in the study and 170 (15.4%) had a history of ASD/ID. ASD/ID youth were more likely to be younger, be male, have histories of violence, and on average have more prior hospitalizations and existing psychotropic prescriptions than their non-ASD/ID counterparts. ASD/ID youth were less likely than their non-ASD/ID peers to be admitted for suicidality and more likely to be admitted for aggression; they had longer average lengths of stay, received more IP emergency medications for agitation, and experienced greater polypharmacy at discharge. The IP psychiatric clinical course of ASD/ID youth differs from that of non-ASD/ID youth, suggesting that ASD/ID youth often present to IP settings with externalizing symptoms. Findings highlight the importance of clinical strategies tailored to the unique needs of ASD/ID youth to improve their care in general IP CAP settings.
PMID: 40437185
ISSN: 1573-3432
CID: 5854652
Evaluating Methods for Imputing Race and Ethnicity in Electronic Health Record Data
Conderino, Sarah; Divers, Jasmin; Dodson, John A; Thorpe, Lorna E; Weiner, Mark G; Adhikari, Samrachana
OBJECTIVE:To compare anonymized and non-anonymized approaches for imputing race and ethnicity in descriptive studies of chronic disease burden using electronic health record (EHR)-based datasets. STUDY SETTING AND DESIGN/METHODS:In this New York City-based study, we first conducted simulation analyses under different missing data mechanisms to assess the performance of Bayesian Improved Surname Geocoding (BISG), single imputation using neighborhood majority information, random forest imputation, and multiple imputation with chained equations (MICE). Imputation performance was measured using sensitivity, precision, and overall accuracy; agreement with self-reported race and ethnicity was measured with Cohen's kappa (κ). We then applied these methods to impute race and ethnicity in two EHR-based data sources and compared chronic disease burden (95% CIs) by race and ethnicity across imputation approaches. DATA SOURCES AND ANALYTIC SAMPLE/UNASSIGNED:Our data sources included EHR data from NYU Langone Health and the INSIGHT Clinical Research Network from 3/6/2016 to 3/7/2020 extracted for a parent study on older adults in NYC with multiple chronic conditions. PRINCIPAL FINDINGS/RESULTS: = 0.33). When these methods were applied to the NYU and INSIGHT cohorts, however, racial and ethnic distributions and chronic disease burden were consistent across all imputation methods. Slight improvements in the precision of estimates were observed under all imputation approaches compared to a complete case analysis. CONCLUSIONS:BISG imputation may provide a more accurate racial and ethnic classification than single or multiple imputation using anonymized covariates, particularly if the missing data mechanism is MNAR. Descriptive studies of disease burden may not be sensitive to methods for imputing missing data.
PMID: 40421571
ISSN: 1475-6773
CID: 5855152
Catecholamine Dysregulation in Former American Football Players: Findings From the DIAGNOSE CTE Research Project
van Amerongen, Suzan; Peskind, Elaine R; Tripodis, Yorghos; Adler, Charles H; Balcer, Laura J; Bernick, Charles; Alosco, Michael L; Katz, Douglas; Banks, Sarah J; Barr, William B; Cantu, Robert C; Dodick, David W; Geda, Yonas E; Mez, Jesse; Wethe, Jennifer V; Weller, Jason L; Daneshvar, Daniel H; Palmisano, Joseph; Fagle, Tess; Holleck, Minna; Kossow, Bailey; Pulukuri, Surya; Tuz-Zahra, Fatima; Colasurdo, Elizabeth; Sikkema, Carl; Iliff, Jeffrey; Li, Ge; Shenton, Martha E; Reiman, Eric M; Cummings, Jeffrey L; Stern, Robert A; ,
BACKGROUND AND OBJECTIVES/OBJECTIVE:Disturbances in brain catecholamine activity may be associated with symptoms after exposure to repetitive head impacts (RHIs) or related chronic traumatic encephalopathy (CTE). In this article, we studied CSF catecholamines in former professional and college American football players and examined the relationship with football proxies of RHI exposure, CTE probability, cognitive performance, neuropsychiatric symptoms, and parkinsonism. METHODS:In this observational cross-sectional study, we examined male former American football players, professional ("PRO") or college ("COL") level, and asymptomatic unexposed male ("UE") individuals from the DIAGNOSE CTE Research Project. Catecholamines-norepinephrine (NE) and its metabolite, 3,4-dihydroxyphenylglycol (DHPG), and dopamine (DA) and its precursor, 3,4-dihydroxyphenylalanine (l-DOPA), and metabolite, 3,4-dihydroxyphenylacetic acid (DOPAC)-were measured in CSF with high-performance liquid chromatography and compared across groups with analysis of covariance. Multivariable linear regression models tested the relationship between CSF catecholamines and proxies of RHI exposure (e.g., total years of playing American football), factor scores for cognition, and neurobehavioral dysregulation (explosivity, emotional dyscontrol, impulsivity, affective lability), as well as depressive/anxiety symptoms, measured with the Beck Depression/Anxiety Inventories. CTE probability and parkinsonism were assessed using the National Institute of Neurological Disorders and Stroke consensus diagnostic criteria for traumatic encephalopathy syndrome (TES), and biomarkers were compared among different diagnostic groups. RESULTS:The cohort consisted of 120 former American football players (85 PRO players, 35 COL players) and 35 UE participants (age 45-75). Former players had significantly lower levels of NE (mean difference = -0.114, 95% CI -0.190 to -0.038), l-DOPA (-0.121, 95% CI -0.109 to -0.027), and DOPAC (-0.116, 95% CI -0.177 to -0.054) than UE participants. For NE and DOPAC, these overall group differences were primarily due to differences between the PRO and UE cohorts. No significant differences were found across TES-CTE probability subgroups or TES-parkinsonism diagnostic groups. Within the COL cohort, tested as post hoc analyses, higher CSF NE and l-DOPA were associated with higher neurobehavioral dysregulation factor scores, BAI total score, and worse executive functioning and processing speed. CSF DHPG and DOPAC were associated with impulsivity only in this subgroup. DISCUSSION/CONCLUSIONS:We observed reduced CSF catecholamine concentrations in former elite American football players, although the relationship with degree of RHI exposure and the clinical impact needs further study.
PMCID:12012624
PMID: 40258206
ISSN: 1526-632x
CID: 5829972